Discover 694 paid clinical trials in Round Rock, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 694
FeaturedActive & Responsive
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
FeaturedActive & Responsive
Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers.
for
Diabetic Foot Ulcer (DFU), Amnio-Maxx
Location: 8 recruiting locations
Sponsor: Royal Biologics
Sex: All
Age: 18+
Code: NCT07209475
Recruiting
Active & Responsive
A Study of Mevidalen (LY3154207) in Participants With Alzheimer's Disease
for
Alzheimer Disease
Location: 40 recruiting locations
Sponsor: Eli Lilly and Company
Sex: All
Age: 50 - 70+
Code: NCT06538116
Phase2, Recruiting
Active & Responsive
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
for
Atopic Dermatitis
Location: 47 recruiting locations
Sponsor: Galderma R&D
Sex: All
Age: 12+
Code: NCT06988605
Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Afimkibart (Also Known as RO7790121) for Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis
for
Moderately to Severely Active Ulcerative Colitis
Location: 79 recruiting locations
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06589986
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis
for
Ulcerative Colitis
Location: 50 recruiting locations
Sponsor: Gilead Sciences
Sex: All
Age: 18 - 70+
Code: NCT06290934
Phase2, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis
for
Moderately to Severely Active Ulcerative Colitis
Location: 44 recruiting locations
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06588855
Phase3, Recruiting
Active & Responsive
Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)
for
Plantar Fibromatosis, Ledderhose Disease
Location: 53 recruiting locations
Sponsor: Endo Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06151197
Phase3, Recruiting
Active & Responsive
A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
for
Moderately to Severely Active Crohns Disease
Location: 76 recruiting locations
Sponsor: Hoffmann-La Roche
Sex: All
Age: 16 - 70+
Code: NCT06819878
Phase3, Recruiting
Active & Responsive
A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer